Bleeding Complications and Reduction of Coagulation Factors

  • Norio Hanafusa


  • Bleeding diathesis during apheresis can be caused by anticoagulant drugs, removal of endogenous coagulating factors, or primary diseases.

  • Monitoring is necessary; activated coagulation time as well as direct measurement of fibrinogen and factor XIII levels is indispensable during plasmapheresis with albumin supplementation including double filtration plasmapheresis.


Coagulation Factor Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Thrombotic Thrombocytopenic Purpura Factor Xiii 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mokrzycki MH et al (1994) Therapeutic plasma exchange: ­complications and management. Am J Kidney Dis 23(6):817–827PubMedGoogle Scholar
  2. 2.
    Kaplan AA (2008) Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis 52(6):1180–1196PubMedCrossRefGoogle Scholar
  3. 3.
    Hanafusa N (2011) Theoretical basis of pathogenic substance removal during plasmapheresis. Ther Apher Dial 15(5):421–430PubMedCrossRefGoogle Scholar
  4. 4.
    Hanafusa N et al (2007) Double filtration plasmapheresis can decrease factor XIII activity. Ther Apher Dial 11(3):165–170PubMedCrossRefGoogle Scholar
  5. 5.
    Hanafusa N et al (2010) Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels. Ther Apher Dial 14(3):287–291PubMedCrossRefGoogle Scholar
  6. 6.
    Gerlach R et al (2000) Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 54(3):260–264 (discussion 264–265)PubMedCrossRefGoogle Scholar
  7. 7.
    Hanafusa N et al (2013) The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation. Transfus Apher Sci (in press)Google Scholar
  8. 8.
    Hanafusa N et al (2010) A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate. Ther Apher Dial 14(4):432–433PubMedCrossRefGoogle Scholar
  9. 9.
    Seishima M et al (2009) Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis. Ther Apher Dial 13(3):229–231PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Department of Hemodialysis & ApheresisUniversity Hospital, The University of TokyoTokyoJapan

Personalised recommendations